Community structure of sulfate reducing bacteria in the sediment of the arctic Smeerenburgfjorden

The community structure of sulfate-reducing bacteria (SRB) of a marine Arctic sediment (Smeerenburgfjorden, Svalbard) was characterized by both fluorescence in situ hybridization (FISH) by using group- and genus-specific 16S rRNA-targeted oligonucleotide probes. Samples stored in PBS-ethanol were diluted and treated by mild sonication. A 10-ml aliquot of a 1:40 dilution was filtered onto a 0.2-mm-pore-size type GTTP polycarbonate filter (Millipore, Eschborn, Germany). Hybridization and microscopic counting of hybridized and 49,69-diamidino-2-phenylindole (DAPI)-stained cells were performed as described previously from Snaidr et al. (1997, http://aem.asm.org/content/63/7/2884.full.pdf). Details of probes and formamide concentrations which were used are listed in futher details.. Means were calculated by using 10 to 20 randomly chosen fields for each filter section, which corresponded to 800 to 1,000 DAPI-stained cells. Counting results were always corrected by subtracting signals observed with probe NON338. The SRB community was dominated by members of the Desulfosarcina-Desulfococcus group. This group accounted for up to 73% of the SRB detected. The predominance was shown to be a common feature for different stations along the coast of Svalbard. In a top-to-bottom approach we aimed to further resolve the composition of this large group of SRB by using probes for cultivated genera. While this approach failed, directed cloning of probe-targeted genes encoding 16S rRNA was successful and resulted in sequences which were all affiliated with the Desulfosarcina-Desulfococcus group. A group of clone sequences (group SVAL1) most closely related to Desulfosarcina variabilis (91.2% sequence similarity) was dominant and was shown to be most abundant in situ, accounting for up to 54.8% of the total SRB detected.

Swellable polymer films containing Au nanoparticles for point-of-care therapeutic drug monitoring using surface-enhanced Raman spectroscopy

Large (10 × 10 cm) sheets of surface-enhanced Raman spectroscopy (SERS) active polymer have been prepared by stabilising metal nanoparticle aggregates within dry hydroxyethylcellulose (HEC) films. In these films the aggregates are protected by the polymer matrix during storage but in use they are released when aqueous analyte droplets cause the films to swell to their gel form. The fact that these "Poly-SERS" films can be prepared in bulk but then cut to size and stored in air before use means that they provide a cost effective and convenient method for routine SERS analysis. Here we have tested both Ag and Au Poly-SERS films for use in point-of-care monitoring of therapeutic drugs, using phenytoin as the test compound. Phenytoin in water could readily be detected using Ag Poly-SERS films but dissolving the compound in phosphate buffered saline (PBS) to mimic body fluid samples caused loss of the drug signal due to competition for metal surface sites from Cl^- ions in the buffer solution. However, with Au Poly-SERS films there was no detectable interference from Cl^- and these materials allowed phenytoin to be detected at 1.8 mg L^-1, even in PBS. The target range of detection of phenytoin in therapeutic drug monitoring is 10-20 mg L^-1. With the Au Poly-SERS films, the absolute signal generated by a given concentration of phenytoin was lower for the films than for the parent colloid but the SERS signals were still high enough to be used for therapeutic monitoring, so the cost in sensitivity for moving from simple aqueous colloids to films is not so large that it outweighs the advantages which the films bring for practical applications, in particular their ease of use and long shelf life.

DISPERSÕES AQUOSAS DE POLIURETANO COMO MATERIAL BASE PARA O DESENVOLVIMENTO DE SISTEMAS DE LIBERTAÇÃO CONTROLADA DE CETOPROFENO

O cetoprofeno (ácido 2-(3-benzoilfenil) propiónico) é um anti-inflamatório não esteroidal (AINE) utilizado no tratamento de uma grande variedade de doenças inflamatórias agudas e crónicas incluindo a artrite reumatoide, osteoartrite e espondilite anquilosante. A sua administração oral prolongada está associada a diversas reações gastrointestinais, tais como irritações e ulcerações. Neste contexto, é importante desenvolver sistemas alternati-vos, nomeadamente sistemas de libertação controlada para administração oral, transdér-mica ou intradérmica. Este trabalho tem como objetivo testar a possibilidade de utilização de dispersões aquosas de poliuretano (PUDs) como material de suporte para a produção de sistemas de liberta-ção controlada de cetoprofeno. Numa primeira etapa, foram sintetizadas PUDs de base poliéster (policaprolactona, PCL) e poliéter (polipropileno-glicol, PPG) utilizando o méto-do de pré-polímero modificado. As dispersões obtidas foram caracterizadas em termos de pH, viscosidade, teor de sólidos e tamanho de partícula. Numa segunda etapa, foi testada a incorporação do cetoprofeno nas PDUs produzidas utilizando duas estratégias para incre-mentar a sua solubilidade em água: (i) utilização de um co-solvente (acetona, DMSO e HYD) e (ii) utilização de um surfactante não iónico (Tween 80). A incorporação foi testada para teores de 5% e 10% (razão fármaco/polímero, m/m). Os filmes produzidos pelo méto-do da evaporação do solvente foram avaliados quanto à sua homogeneidade e caracteriza-dos por FTIR e DSC. Numa terceira fase realizaram-se estudos de libertação em tampão de fosfato salino (PBS) de pH 7.5 tendo como objetivo avaliar a viabilidade de desenvolvimen-to de diferentes tipologias de dispositivos dependendo de um compromisso entre as pro-priedades dos filmes e o comportamento de libertação. Os resultados obtidos podem ajudar na seleção do material de base mais adequado para um determinado fim. Adicionalmente, e mais importante, comprovou-se a viabilidade de utilizar PUDs como material base para o desenvolvimento de sistemas de libertação con-trolada, utilizando como exemplo o cetoprofeno. A avaliação da toxicidade e da atividade anti-inflamatória dos filmes produzidos foi considerada estando em curso neste momento no grupo do Professor Armando Cunha Júnior.

Positive Encounters: An Investigative Study on the Effects of Interactions between Cations and Quantum Dots

Thesis (Ph.D.)--University of Washington, 2016-06

LAPSEN TOIVOTTAVAN KÄYTTÄYTYMISEN EDISTÄMINEN PÄIVÄKOTI- JA ESIOPETUSRYHMÄSSÄ: Lastentarhanopettajien kokemuksia lasten käyttäytymisestä ja käyttäytymisen ohjaamisesta

Tutkimuksen tarkoituksena oli selvittää ja kuvailla, millaista toivottavaa ja ei-toivottua käyttäytymistä lastentarhanopettajat ovat havainneet päiväkoti- ja esiopetusryhmien ruokailu-, leikki- ja ohjatuissa tilanteissa. Lisäksi tutkimuksen tarkoituksena oli selvittää ja kuvailla, miten lastentarhanopettajat näissä tilanteissa pyrkivät edistämään lapsen toivottavaa käyttäytymistä. Tutkimuksen tavoitteena oli löytää toimivia menetelmiä käytännön työhön, tukea lastentarhanopettajien oman toiminnan reflektointia ja kasvatustietoisuutta sekä ylläpitää kasvattajatiimeissä pedagogista keskustelua. Tutkimukseen osallistui yhteensä seitsemän lastentarhanopettajaa erään eteläpohjalaisen kaupungin kahdesta eri päiväkodista. Aineistonkeruumenetelmänä tutkimuksessa käytettiin teemahaastattelua. Haastattelua ohjasi teemarunko, ja haastattelut nauhoitettiin. Puhemuotoinen nauhoitettu aineisto litteroitiin peruslitteroinnin periaatteita noudattaen. Analyysimenetelmänä tutkimuksessa käytettiin teemoittelua, ja sisällönanalyysi oli muodoltaan teoriasidonnaista eli teoriaohjaavaa. Haastatteluun osallistuneiden lastentarhanopettajien havaintojen mukaan ruokailu-, leikki- ja ohjatuissa tilanteissa esiintyy monenlaisia toivottavan ja ei-toivotun käyttäytymisen muotoja. Lastentarhanopettajat tukevat toivottavaa ja ennaltaehkäisevät ei-toivottua käyttäytymistä erilaisilla lapsen käyttäytymiseen, varhaiskasvatusympäristön fyysisiin, sosiaalisiin ja psyykkisiin tekijöihin sekä itseensä kohdistuvilla menetelmillä. Ei-toivottua käyttäytymistä lastentarhanopettajat ohjaavat toivottavaan suuntaan erilaisilla lapsen käyttäytymiseen kohdistuvilla pehmeillä, sovitteluun perustuvilla sekä kovilla ja ankarilla menetelmillä tai itseensä kohdistuvilla menetelmillä. Tämän tutkimuksen myötä varhaiskasvatusta toteuttavia kasvatus- ja opetusalan ammattilaisia kannustetaan pohtimaan kriittisesti, millaista käyttäytymistä he lapselta eri tilanteissa odottavat ja miksi. Lisäksi esimerkiksi PBS- ja ProKoulu-toimintamallien sekä tämän tutkimuksen tulosten pohjalta voitaisiin ryhtyä kehittämään suomalaiseen varhaiskasvatukseen soveltuvaa lapsen toivottavaa käyttäytymistä tukevaa toimintamallia. Yhteisen toimintamallin myötä varhaiskasvattajien ei jatkossa tarvitsisi ohjata lapsen käyttäytymistä kovilla ja ankarilla menetelmillä, sillä toimintamallissa keskityttäisiin toivottavan käyttäytymisen tukemiseen ja ei-toivotun käyttäytymisen ennaltaehkäisyyn tutkimusnäyttöön perustuvilla menetelmillä.

Avaliação da interação entre aflatoxina M1 e B1 com a fração proteica do leite

Dissertação composta por 02 artigos.

Transdermal delivery of cyclosporin A by electrically enhanced permeation techniques

Transdermal drug delivery has recently received increasing attention in the face of growing challenges to deliver peptide and protein drugs. Controlled transdermal delivery is an important route for the delivery of peptides and proteins that can maintain the therapeutic effectiveness of the drug by minimizing enzymatic degradation which is a major concern in other noninvasive routes of delivery such as the oral route. Although the advantages of transdermal delivery are very desirable, the natural obstacle to drug entry imposed by the skin's barrier function makes it one of the most difficult route of administration. Iontophoresis and electroporation have been reported to be useful as permeation enhancing techniques in the transdermal delivery of protein and peptide drugs. The objective of present study is to use the above enhancement techniques to deliver cyclosporin A (CSA) to treat psoriasis. The in vitro experiments were performed using hairless rat skin as the model with Franz diffusion cells for iontophoresis and custom made diffusion cells for electroporation. The donor drug solution of CSA consisted of an aqueous solution of CSA - polymer solid dispersion, coevaporate, and/or a hydroethanolic solution of CSA PBS was used as the receiver solution. ³H labelled CSA and ¹⁴C labelled ethanol were used to facilitate analysis using a liquid scintillation counter. The control experiment consisted of passive diffusion study. Silver/silver chloride electrodes were used in all studies. In the iontophoresis experiments a constant DC current (0.5 mA/cm²) was used. In the electroporation experiments different delivery parameters were studied: (1) applied electrode voltage (Uelectrode), (2) decay time constant (τ), (3) the number of pulses delivered - single or multiple, and { 4) the time of diffusive contact with drug after electroporation ('contact duration'). Compared to the passive diffusion, iontophoresis did not result in a significant increase in the amount of CSA delivered transdermally with both the CSA-polymer donor and hydroethanolic drug solutions. With the use of electroporation there was a significant increase in the transdermal delivery, compared to passive transport. With the CSA-polymer coevaporate donor solution the increase in delivery was only about 6 fold higher whereas with the hydroethanolic solution the increase was about 60 times higher compared to passive diffusion. The 'contact duration• was an important fader and a 4-hour 'contact duration' was found to be the optimum time period required for effective transdermal delivery. Use of single pulse (τ=5.6 ms) electroporation resulted in a significant increase {p<0.05) in the delivery of CSA in skin {CSA.n) and EtOH in receiver (EtOHreceiver). With multiple pulse (τ=10 ms. 25 pulses) the increase in CSAskin was more pronounced with a 60 fold increase than compared to the passive delivery. However there was no significant increase in the other two quantities viz. CSAreceiver, and EtCHreceiver.

Double hydrophilic polyphosphoester containing copolymers as efficient templating agents for calcium carbonate microparticles

International audience

Superparamagnetic Liposomes for MRI Monitoring and External Magnetic Field-Induced Selective Targeting of Malignant Brain Tumors

International audience

Soybean lunasin mediates colon carcinogenesis by inducing apoptosis and preventing outgrowth of metastasis

Colorectal cancer (CRC) is the third most common cancer worldwide. Various factors such as age, lifestyle and dietary patterns affect the risk of having CRC. Epidemiological studies showed a chemopreventive effect of soy consumption against CRC. However, which component(s) of soybean is associated with this reduced risk is not yet fully delineated. The objective of this research was to evaluate the anti-colon cancer potential of lunasin isolated from defatted soybean flour using in vitro and in vivo models of CRC. Lunasin was isolated from defatted soybean flour by a combination of different chromatographic and ultrafiltration techniques. The anti-colon cancer potential of lunasin was determined using different human colon cancer cell lines in vitro and a CRC liver metastasis model in vivo. Lunasin caused cytotoxicity to different human colon cancer cells with an IC50 value of 13.0, 21.6, 26.3 and 61.7 µM for KM12L4, RKO, HCT-116 and HT-29 human colon cancer cells, respectively. This cytotoxicity correlated with the expression of the α5 integrin on human colon cancer cells with a correlation coefficient of 0.78. The mechanism involved in the cytotoxic effect of lunasin was through cell cycle arrest and induction of the mitochondrial pathway of apoptosis. In KM12L4 human colon cancer cells, lunasin caused a G2/M phase arrest increasing the percentage of cells at G2/M phase from 12% (PBS-treated) to 24% (treated with 10 µM lunasin). This arrest was attributed to the capability of lunasin to increase the expression of cyclin dependent kinase inhibitors p21 and p27. At 10 µM, lunasin increased the expression of p21 and p27 in KM12L4 colon cancer cells by 2.2- and 2.3-fold, respectively. Flow cytometric analysis showed that lunasin at 10 µM increased the percentage of cells undergoing apoptosis from 13.6% to 24.7%. This is further supported by fluorescence microscopic analysis of KM12L4 cells treated with 10 µM lunasin showing chromatin condensation and DNA fragmentation. The mechanism involved is through modification of proteins involved in the mitochondrial pathway of apoptosis in KM12L4 cells as 10 µM lunasin reduced the expression of the anti-apoptotic Bcl-2 protein by 2-fold and increased the expression of the pro-apoptotic proteins Bax, cytochrome c and nuclear clusterin by 2.2-, 2.1- and 2.3- fold, respectively. This led to increased expression and activity of the executioner of apoptosis, caspase-3 by 1.8- and 2.3-fold, respectively. This pro-apoptotic property of lunasin can be attributed to its capability to internalize into the cytoplasm and nucleus of colon cancer cells 24 h and 72 h after treatment, respectively. In addition, lunasin mediated metastasis of colon cancer cells in vitro by inhibiting the focal adhesion kinase activation thereby reducing expression of extracellular regulated kinase and nuclear factor kappa B and finally inhibiting migration of colon cancer cells. In KM12L4 colon cancer cells, 10 µM lunasin resulted in the reduction of phosphorylation of focal adhesion kinase and extracellular regulated kinase by 2.5-fold, resulting in the reduced nuclear translocation of p50 and p65 NF-κB subunits by 3.8- and 1.4-fold, respectively. In an in vivo model of CRC liver metastasis, daily intraperitoneal administration of lunasin at 4 mg/kg body weight resulted in the inhibition of KM12L4 liver metastasis as shown by the reduction of the number of liver metastases from 28 (PBS-treated) to 14 (lunasin-treated, P = 0.047) and reduction in tumor burden as measured by liver weight/body weight from 0.13 (PBS-treated) to 0.10 (lunasin-treated, P = 0.039). Moreover, lunasin potentiated the anti-metastatic effect of the chemotherapeutic drug oxaliplatin given at 5 mg/kg body weight twice per week. Lunasin and oxaliplatin combination resulted in a more potent inhibition of outgrowth of KM12L4 cell metastases to the liver reducing the number of liver metastases by 6-fold and reducing the tumor burden in the liver by 3-fold when compared to PBS-treated group. This can be attributed by the capability of lunasin and oxaliplatin to reduce expression of proliferating cell nuclear antigen in liver-tumor tissue as measured by immunohistochemical staining. The results of this research for the first time demonstrated the anti-colon cancer potential of lunasin isolated from defatted soybean flour which might contribute to the chemopreventive effect of soybean in CRC as seen in different epidemiological studies. In conclusion, lunasin isolated from defatted soybean flour mediated colon carcinogenesis by inducing apoptosis and preventing outgrowth of metastasis. We suggest that the results of this research serve as a basis for further study on the chemopreventive effect of lunasin against CRC and a possible adjuvant role for lunasin in therapy of patients with metastatic CRC.